Skip to main content
Novartis
language-selector-globe Austria | de
Standort wählen
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe Austria
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • Über Uns 
      • Was wir tun 
        • Unsere Werte 
      • Geschichte 
        • Mehr als 75 Jahre Novartis in Österreich 
      • Forschung & Entwicklung 
      • Management 
      • Standorte in Österreich 
      • Unsere Strategie 
      • Diversity and Inclusion 
      • Arbeiten bei Novartis Österreich 
      • Produkte 
      Über uns Über Uns
    • Betroffene & Angehörige 
      • Unser Versprechen an Patientinnen und Patienten 
      • Patient Engagement 
        • Diabetisches Makulaödem (DMÖ) 
        • Brustkrebs 
        • Altersbedingte Makuladegeneration (AMD) 
        • Erblich bedingte Netzhautdystrophien (IRD) 
        • Webseiten & Apps 
      • Erkrankungen & Therapien 
        • Atemwegserkrankungen 
        • Augenerkrankungen 
        • Dermatologie 
        • Hämatologie 
        • Herz-Kreislauf-Erkrankungen 
        • Onkologie 
        • Rheumatologie 
        • Transplantation 
      • Produkte 
        • Innovative Medikamente 
        • Generika & Biosimilars 
        • Gen & Zelltherapien 
        • Produkte von A-Z 
      • Nebenwirkungen melden 
      • Klinische Studien 
        • Allgemeines 
        • Wissenswertes zu klinischen Studien 
        • Aktuelle Studien 
          • Chronische Myeloische Leukämie in der chronischer Phase (CML-CP): CABL001A2302 
        • Fachausdrücke 
        • Häufig gestellte Fragen zur Studienteilnahme 
        • Onkologische Studien 
      • Fragen & Nebenwirkungen 
        • Meine Fragen - medizinischen Informationsdienst von Novartis 
        • Meine Fragen - Arzt 
        • Meine Fragen - Apotheker 
      • Patientenportal 
      Teaser Patient*innen & Angehörige 280px Betroffene & Angehörige
    • Fachkreise 
      • Serviceportal 
      • Produkte 
      • Novartis Pipeline 
      • Nebenwirkungen melden 
      • Aktuelle Klinische Studien 
      • Novartis Clinical Trials 
      • Terminanfrage 
      Teaser Fachkreise 280px Fachkreise
    • Nachhaltigkeit 
      • Unternehmensethik 
        • Offenlegungen 
      • Zugang zu Medikamenten 
      • Umwelt & Gesellschaft 
      • Ethik, Risiko und Compliance 
        • SpeakUp 
      Nachhaltigkeit Nachhaltigkeit
    • Medien 
      • Pressemitteilungen 
      • Geschichten 
      • Unternehmenspublikationen 
      • Bildmaterial 
      • Medienkontakt 
    • Kontakt 
    • Karriere 
      • Jobsuche 
      • Arbeiten bei Novartis Österreich 
        • Sommer-/Ferialpraktikum 2024 
      • Mitarbeitende 
      • Karriere-Programme 
      • Lehre 
      • Meet the teams 
      Teaser Karriere 525x280px Karriere
    Banner Novartis Medien Startseite
  1. Home
  2. Karriere
  3. Jobsuche
  • Sort by Sort ascending
  • Positionsbezeichnung Sort descending
  • Site
  • Standort
  • Division
  • Business
  • Functional Area
  • Erscheinungsdatum
Positionsbezeichnung Sort descending Site Standort Division Business Functional Area Erscheinungsdatum
Analyst – Patient Oriented Programs Hyderabad (Office) Indien Operations CTS Marketing Mai 20, 2024
Analyst – Quality Operations Hyderabad (Office) Indien Operations Innovative Medicines Quality Okt 10, 2024
Analyst Quality Operations Hyderabad (Office) Indien Operations Innovative Medicines Quality Sep 20, 2024
Analyst Social Media Listening Hyderabad (Office) Indien Operations CTS Marketing Okt 22, 2024
Analyst Stratégique H/F) en Stage Rueil-Malmaison Frankreich International Innovative Medicines Others Aug 19, 2024
Analytical Expert – Trace Level Analytics (m/f/d) Basel (City) Schweiz Development Innovative Medicines Research & Development Okt 25, 2024
Analytical Expert (Associate Director, Science & Technology) Basel (City) Schweiz Development Innovative Medicines Research & Development Okt 10, 2024
APPRENTI(E) ANIMATEUR SSE (H/F) Huningue Frankreich Operations Innovative Medicines Others Jun 10, 2024
APPRENTI(E) COORDINATEUR FORMATION (H/F) Huningue Frankreich Operations Innovative Medicines Others Mai 31, 2024
Area Marketing Manager Chengdu (Sichuan Province) China International Innovative Medicines Marketing Apr 30, 2024
Area Marketing Manager Wuhan (Hubei Province) China International Innovative Medicines Marketing Mai 06, 2024
AS&T ekspert (m/ž/d) Ljubljana Slowenien Operations Innovative Medicines Quality Sep 09, 2024
AS&T Expert Schaftenau Österreich Operations Innovative Medicines Quality Okt 14, 2024
AS&T Expert Schaftenau Österreich Operations Innovative Medicines Quality Okt 24, 2024
AS&T Expert - Quality Operations Hyderabad (Office) Indien Operations Innovative Medicines Quality Sep 03, 2024
AS&T Expert (Micro) Tuas South Avenue Singapur Operations Innovative Medicines Quality Okt 01, 2024
AS&T Hub Team Coordinator İstanbul Kurtköy Türkei Operations Innovative Medicines Quality Sep 03, 2024
AS&T Specialist İstanbul Kurtköy Türkei Operations Innovative Medicines Quality Sep 03, 2024
AS&T Specialist Schaftenau Österreich Operations Innovative Medicines Quality Okt 24, 2024
AS&T Specialist - Quality Operations Hyderabad (Office) Indien Operations Innovative Medicines Quality Sep 03, 2024
AS&T specialist (m/ž/d) Mengeš Slowenien Operations Innovative Medicines Quality Okt 23, 2024
AS&T specialist (m/ž/d) Mengeš Slowenien Operations Innovative Medicines Quality Okt 23, 2024
AS&T specialist (m/ž/d) Ljubljana Slowenien Operations Innovative Medicines Quality Okt 17, 2024
ASCVD Brand Manager Seoul Südkorea International Innovative Medicines Marketing Sep 03, 2024
Asset Strategy Lead - Automation (80-100%*) Basel (City) Schweiz Biomedical Research Pharma Research Research & Development Okt 14, 2024
Asset Strategy Lead - Biologics Analysis (80-100%*) Basel (City) Schweiz Biomedical Research Pharma Research Research & Development Sep 27, 2024
Asset Strategy Lead – Automation Cambridge (USA) USA Biomedical Research Pharma Research Research & Development Sep 27, 2024
Asset Strategy Lead – Biologics Analysis Cambridge (USA) USA Biomedical Research Pharma Research Research & Development Sep 27, 2024
Assistant(e) de Coordination Accès au Marché H/F Paris Headquarter (Novartis Pharma S.A.S.) Frankreich International Innovative Medicines Market Access Okt 22, 2024
Assistant(e) de Coordination Senior H/F CDD Paris Headquarter (Novartis Pharma S.A.S.) Frankreich International Innovative Medicines Einrichtungen und Verwaltung Sep 23, 2024
Assoc Director - Service Management (ITIL , ITSM - Salesforce) Hyderabad (Office) Indien Operations CTS Technology Transformation Okt 15, 2024
Assoc. Dir Content Engineering(Azure -AWS-Application management Documentum) Hyderabad (Office) Indien Operations CTS Technology Transformation Sep 03, 2024
Assoc. Dir. DDIT APD CE Service Mgmt. INSURGENTES Mexiko Operations CTS Technology Transformation Okt 18, 2024
Assoc. Dir. DDIT APD ERP Commercials and Cross Functional Santo Amaro Brasilien Operations CTS Technology Transformation Sep 03, 2024
Assoc. Dir. DDIT APD ERP PlatformTech Se Hyderabad (Office) Indien Operations CTS Technology Transformation Mai 09, 2024
Assoc. Dir. DDIT Dev. Business Analyst, Global Clinical Operations Barcelona Gran Vía Spanien Operations CTS Technology Transformation Aug 21, 2024
Assoc. Dir. DDIT Dev. GCO Tech. Design (Technical Business Analyst) Hyderabad (Office) Indien Operations CTS Technology Transformation Aug 05, 2024
Assoc. Dir. DDIT IES Cloud Engineering Hyderabad (Office) Indien Operations CTS Technology Transformation Okt 11, 2024
Assoc. Dir. DDIT ISC Ent Arch Digit Sec Hyderabad (Office) Indien Operations CTS Technology Transformation Apr 16, 2024
Assoc. Dir. DDIT ISC Gov SOX IT Testing Hyderabad (Office) Indien Operations CTS Technology Transformation Sep 20, 2024
Assoc. Dir. DDIT ISC SecOps VulnSvcs Hyderabad (Office) Indien Operations CTS Technology Transformation Okt 09, 2024
Assoc. Dir. DDIT ISC VulnSvcs role Hyderabad (Office) Indien Operations CTS Technology Transformation Apr 17, 2024
Assoc. Dir. DDIT LDC Platform Mgt(SAP Solution Manager) Hyderabad (Office) Indien Operations CTS Technology Transformation Okt 25, 2024
Assoc. Dir. DDIT OPX Planning Prague Tschechische Republik Operations CTS Technology Transformation Apr 29, 2024
Assoc. Dir. DDIT US&I Service Management Access Hyderabad (Office) Indien Operations CTS Technology Transformation Okt 04, 2024
Assoc. Dir. Platform Analytics Architecture Hyderabad (Office) Indien Operations CTS Technology Transformation Sep 03, 2024
Assoc. Dir. Solution Delivery - SAP FICO Barcelona Gran Vía Spanien Operations CTS Technology Transformation Okt 10, 2024
Assoc. Director- Solutions Delivery (SAP Business Process Automation) Hyderabad (Office) Indien Operations CTS Technology Transformation Okt 23, 2024
Assoc. Director, Business Analyst, Global Clinical Supply Barcelona Gran Vía Spanien Operations CTS Technology Transformation Aug 13, 2024
Assoc. Director, Business Analyst, Technical Research & Development (TRD) Barcelona Gran Vía Spanien Operations CTS Technology Transformation Aug 13, 2024

Pagination

  • ‹ Previous page
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • …
  • 42
  • › Next page

Novartis Österreich

Novartis entdecken
  • Über Uns
  • Betroffene & Angehörige
  • Fachkreise
  • Medien
  • Karriere
Medienbereich
  • Pressemitteilungen
  • Geschichten
Unser Portfolio
  • Arzneimittel der Novartis
Weitere Novartis Websites
  • Healthcare Professional Resources
  • Global site
Footer Bottom
© 2024 Novartis Pharma GmbH
  • Datenschutzerklärung
  • Nutzungsbedingungen
  • Über Cookies
  • Impressum
  • Cookie-Einstellungen
  • Barrierefreiheit im Internet
  • Site Map
Novartis Site Directory
Diese Website richtet sich an Personen in Österreich.